Best Digital Twins & Biosimulation Companies

Aitia focuses on the development and application of Causal AI and Digital Twins in the pharmaceutical industry. The company's main services include the discovery of drugs for neurodegenerative disorders, oncology, and immunology by revealing hidden biological mechanisms of diseases and creating Digital Twins. It is used to discover novel therapies and accelerate research and development in various diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, multiple myeloma, prostate cancer, and pancreatic cancer. It was founded in 2000 and is based in Cambridge, Massachusetts.

InSilicoTrials is a technology company that utilizes computational models and artificial intelligence in the life sciences sector. The company provides a cloud-based platform for modeling and simulation, aimed at assisting clients in the research and development (R&D) process for medical products. InSilicoTrials serves the pharmaceutical and medical device industries by offering tools that support the development of new drugs and devices. It was founded in 2016 and is based in Trieste, Italy.

VeriSIM Life is a company focused on the pharmaceutical research and development sector, with a particular emphasis on drug discovery and development technology. The company offers a platform that uses artificial intelligence to accelerate and de-risk the process of translating drug candidates to clinical trials, predicting patient outcomes, and providing insights for pharmaceutical companies, biotechs, and academic & research institutions. Its services are primarily utilized in the pharmaceutical research and development industry. It was founded in 2017 and is based in San Francisco, California.

Akkure Genomics specializes in the integration of artificial intelligence and genomics within the cancer trial recruitment sector. The company offers a digital platform that matches patients with clinical trials using AI and genomic data. It primarily serves the healthcare sector, including hospitals, charities, pharmacies, and government bodies, by providing solutions that facilitate access to clinical trials. It was founded in 2019 and is based in Dublin, Ireland.

DeepLife is a biotech company focused on leveraging digital twins of cells for drug discovery. They develop a SaaS platform that utilizes multi-omics data, AI, and systems engineering to identify molecular triggers that can revert diseased cells to a healthy state. The company primarily serves the biotech and pharmaceutical industries by accelerating target identification processes and collaborating with the academic community. It was founded in 2019 and is based in Vernon, France.

GenHealth AI specializes in generative artificial intelligence within the healthcare domain. The company offers solutions for automating prior authorization, managing population health, and providing insights into healthcare economics and patient care quality. Its products are primarily utilized by entities in the healthcare industry, including insurance plans, pharmaceutical companies, healthcare providers, and life sciences organizations. The company was founded in 2023 and is based in Vienna, Virginia.

Twin Health specializes in the management of chronic metabolic diseases within the healthcare sector. The company offers a comprehensive program that utilizes Digital Twin AI technology and personalized health recommendations to help individuals improve their metabolic health. Twin Health primarily serves employees and health plan members, providing tailored solutions to prevent and reverse conditions such as diabetes and prediabetes, while also aiming to reduce dependency on medications and overall healthcare costs. Twin Health was formerly known as Twins Digital. It was founded in 2018 and is based in Mountain View, California.

Unlearn builds machine-learning platforms to create biological digital twins for the healthcare and pharmaceutical industries. It develops generative machine learning methods to predict individual health outcomes and accelerate clinical innovation. It connects with biopharma companies and regulators to ensure its methods meet scientific and regulatory standards. It was founded in 2017 and is based in San Fransisco, California.